药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02268 药明合联

已收盘 12-19 16:08:47

31.600

+0.300

+0.96%

最高32.200	最低30.400	成交量182.84万
今开30.900	昨收31.300	日振幅5.75%
总市值379.20亿	流通市值379.20亿	总股本12.00亿
成交额5,781万	换手率0.15%	流通股本12.00亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":31.6,"timestamp":1734595727014,"preClose":31.3,"halted":0,"volume":1828446,"delay":0,"floatShares":1200000000,"shares":1200000000,"eps":0.29731843,"marketStatus":"已收盘","marketStatusCode":5,"change":0.3,"latestTime":"12-19 16:08:47","open":30.9,"high":32.2,"low":30.4,"amount":57813236,"amplitude":0.057508,"askPrice":31.75,"askSize":9500,"bidPrice":31.55,"bidSize":34000,"shortable":3,"etf":0,"ttmEps":0.5277473704452497,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1700150400000,"adjPreClose":31.3,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":0.470133,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"1134817218","title":"《生物安全法案》未被美国国会纳入2025年持续拨款和延期法案","url":"https://stock-news.laohu8.com/highlight/detail?id=1134817218","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134817218?lang=zh_cn&edition=full","pubTime":"2024-12-18 15:56","pubTimestamp":1734508611,"startTime":"0","endTime":"0","summary":"也未出现药明系和华大智造等相关实体名称。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688114","02269","02359","02268"],"gpt_icon":0},{"id":"2492601949","title":"南向资金12月17日净卖出药明合联205.65万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492601949","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492601949?lang=zh_cn&edition=full","pubTime":"2024-12-18 09:30","pubTimestamp":1734485421,"startTime":"0","endTime":"0","summary":"12月17日，南向资金减持药明合联205.65万股连续3日减持。截止当日收盘，港股通共持有药明合联11389.07万股，占流通股9.49%。药明合联近5个交易日下跌2.54%，港股通累计减持749.00万股；近20个交易日上涨23.79%，港股通累计增持257.86万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093637ab807e11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218093637ab807e11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2491884657","title":"药明合联12月16日主力资金流出419万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2491884657","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491884657?lang=zh_cn&edition=full","pubTime":"2024-12-16 16:17","pubTimestamp":1734337030,"startTime":"0","endTime":"0","summary":"12月16日, 药明合联股价跌3.85%，报收30.00元，成交金额2.22亿元，换手率0.61%，振幅6.41%，量比1.28。药明合联今日主力资金净流出419万元，连续3日净流出，上一交易日主力净流出510万元，今日环比减少17.84%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为33.33%，平均跌幅为2.54%。该股近5个交易日下跌5.67%，主力资金累计净流出416万元；近20日主力资金累计净流入6802万元，其中净流入天数为13日。该股主力净额占比0.01%，港股市场排名2422/2651。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161757a1f27ae2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216161757a1f27ae2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2491324316","title":"国金证券：年底集采预期陆续出清 医药板块行情有望逐步启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2491324316","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491324316?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:21","pubTimestamp":1734330091,"startTime":"0","endTime":"0","summary":"随着集采控费的忧虑情绪进一步出清，以及国内医药创新成果不断涌现，医药板块行情有望逐步启动；国家支持创新药的各种政策逐步落地，中国药企创新实力及其成长空间还远未被资本市场所充分认知。随着集采控费的忧虑情绪进一步出清，以及国内医药创新成果不断涌现，医药板块行情有望逐步启动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","BK1161","BK1141","SG9999014674.SGD","BK0028","159938","LU0196878994.USD","BK1515","BK0276","BK0188","BK0183","09939","BK0201","BK1574","BK0012","06990","600109"],"gpt_icon":0},{"id":"2491634368","title":"药明合联12月13日遭主力抛售510万元 环比增加124.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491634368","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491634368?lang=zh_cn&edition=full","pubTime":"2024-12-13 16:15","pubTimestamp":1734077733,"startTime":"0","endTime":"0","summary":"12月13日, 药明合联股价跌0.48%，报收31.20元，成交金额1.04亿元，换手率0.28%，振幅3.03%，量比0.52。药明合联今日主力资金净流出510万元，上一交易日主力净流出227万元，今日环比增加124.67%。该股近5个交易日上涨9.04%，主力资金累计净流入1147万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入6661万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161550ab74bfbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213161550ab74bfbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2490879827","title":"【券商聚焦】浦银国际对2025年医药板块整体呈乐观态度 看好创新药、医疗器械及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879827","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490879827?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:52","pubTimestamp":1733989962,"startTime":"0","endTime":"0","summary":"2)医疗器械：看好创新高值耗材、医疗设备板块。康诺亚核心产品CM310将于2025年迎来首个完整年度商业化，作为首个国产重磅IL4R，该行认为其市场潜力巨大。此外，康诺亚研发实力强劲，NewCo形式有助于加快其出海步伐，2025年潜在出海交易有望进一步提振股票行情。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422366.SGD","159883","06978","02359","LU0359202008.SGD","LU1720050803.USD","SG9999002562.SGD","LU0823426308.USD","00013","BK1610","02190","LU0043850808.USD","BK1100","LU0307460666.USD","IE00B5MMRT66.SGD","LU0327786744.USD","159992","LU0348735423.USD","LU0979878070.USD","09939","02269","LU0417516738.SGD","LU0819121731.USD","01789","09997","LU2328871848.SGD","BK1191","LU0196878994.USD","159938","LU0572944931.SGD","LU0181495838.USD","02162","06990","02268","06160","BK1141","09996","BK1521","BK1589","03759","09926","CXO","LU0856984785.SGD","LU2125910500.SGD","LU0348784397.USD","LU2488822045.USD","LU2045819591.USD","SG9999002463.SGD","IE00B543WZ88.USD","SG9999014674.SGD"],"gpt_icon":1},{"id":"2490825750","title":"【券商聚焦】野村料中国医药行业明年首季增速可回升 看好百济神州(06160)及药明合联(02268)","url":"https://stock-news.laohu8.com/highlight/detail?id=2490825750","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490825750?lang=zh_cn&edition=full","pubTime":"2024-12-12 12:22","pubTimestamp":1733977355,"startTime":"0","endTime":"0","summary":"金吾财讯 | 野村中国医药保健行业研究部主管张佳林指，今年中国医疗市场仍面对困境，等待复苏。展望未来，他指，有不少企业近年致力于拓展海外市场，同时近期以来国家医保局多次公开探讨商业健康险发展，对创新药普及有帮助。张佳林预计，在低基数及潜在需求逐步释放下，明年首季及上半年行业收入增长将重新加快，看好GLP-1新药及抗体偶联药物ADC等前景，又指行业估值处于较低水平，亦为未来的反弹提供基础，在生物科技股中较看好百济神州(06160)，认为其海外市场特别是美国地区销售表现强劲，而在CRO板块则看好药明合联(02268)的高增长潜力及合理估值。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/Y2EzOTlkNjExODQ0M2ZhODVjNjcxNDk5OTNhMDU4MjE2MzgxODI2NTQy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2EzOTlkNjExODQ0M2ZhODVjNjcxNDk5OTNhMDU4MjE2MzgxODI2NTQy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949502","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0239","BK0010","BK0028","BK4139","02268","BK1161","BK1588","BK1500","BK0250","600056","BK4548","688235","LU0588546209.SGD","BK0082","BK4526","BGNE","BK1583","06160","LU2328871848.SGD","BK4505","BK1141","LU0307460666.USD","BK4504","BK4588","BK4535","SG9999014674.SGD","BK0188","LU1969619763.USD","BK0175","BK4585"],"gpt_icon":0},{"id":"2490462248","title":"药明合联12月11日遭南向资金减持357.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490462248","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490462248?lang=zh_cn&edition=full","pubTime":"2024-12-12 09:30","pubTimestamp":1733967022,"startTime":"0","endTime":"0","summary":"12月11日，南向资金减持药明合联357.38万股。截止当日收盘，港股通共持有药明合联11780.69万股，占流通股9.81%。药明合联近5个交易日上涨14.29%，港股通累计减持76.68万股；近20个交易日上涨22.37%，港股通累计增持1331.48万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093224a1e7a8d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212093224a1e7a8d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD"],"gpt_icon":0},{"id":"2490690880","title":"药明合联12月11日获主力加仓625万元 环比增加453.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490690880","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490690880?lang=zh_cn&edition=full","pubTime":"2024-12-11 16:15","pubTimestamp":1733904904,"startTime":"0","endTime":"0","summary":"12月11日, 药明合联股价涨1.59%，报收32.00元，成交金额9973万元，换手率0.26%，振幅4.44%，量比0.53。药明合联今日主力资金净流入625万元，连续4日净流入，上一交易日主力净流入113万元，今日环比增加453.10%。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为63.64%，平均涨幅为3.13%。该股近5个交易日上涨14.29%，主力资金累计净流入2447万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入7805万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161506a1e59c46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211161506a1e59c46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","BK1141"],"gpt_icon":0},{"id":"2490887512","title":"【券商聚焦】华泰证券升药明合联(02268)目标价33.91% 指生物安全法案立法受阻 有望维持行业领先地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2490887512","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490887512?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:46","pubTimestamp":1733903184,"startTime":"0","endTime":"0","summary":"药明合联为全球竞争力强劲的ADCCDMO，ADC赛道正高速发展且相关产能持续紧张，在生物安全法案快速立法受阻背景下，该行看好公司收入维持高速增长。该行表示，生物安全法案可通过单独立法以及预算法案夹带两种途径成为美国法律。因该法案内容未纳入2025财年NDAA，短期夹带途径快速立法难度已较大。2025年1月118届国会任期结束后，未通过的法案将失效，提案方需要向119届国会重新提交草案，从头审议生物安全法案，周期较长。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/ZWZlMGNjODY1NzQ4NjMzODA5NjU5ODM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZWZlMGNjODY1NzQ4NjMzODA5NjU5ODM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06886","02268"],"gpt_icon":0},{"id":"2490008668","title":"药明合联12月10日获南向资金加仓212.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490008668","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490008668?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:30","pubTimestamp":1733880619,"startTime":"0","endTime":"0","summary":"12月10日, 南向资金增持药明合联212.95万股。截止当日收盘，港股通共持有药明合联12138.07万股，占流通股10.11%。药明合联近5个交易日上涨12.50%，港股通累计增持393.99万股；近20个交易日上涨18.20%，港股通累计增持1880.66万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211093216a1e4be9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211093216a1e4be9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","BK1141"],"gpt_icon":0},{"id":"2490066285","title":"药明合联12月10日主力资金流入113万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490066285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490066285?lang=zh_cn&edition=full","pubTime":"2024-12-10 16:16","pubTimestamp":1733818606,"startTime":"0","endTime":"0","summary":"12月10日, 药明合联股价跌0.79%，报收31.50元，成交金额2.17亿元，换手率0.56%，振幅8.19%，量比1.24。药明合联今日主力资金净流入113万元，连续3日净流入，上一交易日主力净流入1144万元，今日环比减少90.12%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为64.71%，平均涨幅为3.28%。该股近5个交易日上涨12.14%，主力资金累计净流入1473万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入7465万元，其中净流入天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210161734ab6c31d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210161734ab6c31d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"2490034591","title":"药明合联盘中异动 早盘股价大涨5.20%报33.400港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490034591","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490034591?lang=zh_cn&edition=full","pubTime":"2024-12-10 09:30","pubTimestamp":1733794244,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘09时30分，药明合联股票出现异动，股价大幅拉升5.20%。截至发稿，该股报33.400港元/股，成交量9.3万股，换手率0.01%，振幅3.78%。资金方面，该股资金流入136.6万港元，流出66.4125万港元。药明合联股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，药明巨诺-B、欧康维视生物-B、复旦张江涨幅较大，振幅较大的相关个股有康诺亚-B、腾盛博药-B、欧康维视生物-B，振幅分别为4.77%、4.26%、4.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093044984ae043&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210093044984ae043&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268"],"gpt_icon":0},{"id":"2490718823","title":"美生物安全法案“生变”，CRO概念大举反攻，药明系嗨了！","url":"https://stock-news.laohu8.com/highlight/detail?id=2490718823","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490718823?lang=zh_cn&edition=full","pubTime":"2024-12-09 12:10","pubTimestamp":1733717419,"startTime":"0","endTime":"0","summary":"行业悲观预期或好转","market":"us","thumbnail":"https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/25d53-cb9c4747-fd5c-4169-a43e-056e33d68b09.jpg?guru_height=718&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1449943","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0051755006.USD","LU0307460666.USD","LU0456842615.SGD","LU1794554557.SGD","BK0216","LU0348825331.USD","SG9999002562.SGD","LU1688375341.USD","BK1576","LU1242518931.SGD","BK0028","LU2488822045.USD","02359","SG9999014674.SGD","BK0077","LU0327786744.USD","BK1521","LU1880383366.USD","LU0043850808.USD","LU0359201612.USD","LU0052750758.USD","02268","LU0572944931.SGD","LU2039709279.SGD","NDAA","LU0456827905.SGD","LU0359202008.SGD","LU0819121731.USD","BK0042","BK1141","LU0348735423.USD","BK0086","LU0856984785.SGD","301201","BK1583","LU0320764599.SGD","LU1046422090.SGD","300149","BK0102","LU0823426308.USD","BK0081","LU0456846285.SGD","LU1997245177.USD","LU2242644610.SGD","LU0823426480.USD","LU0516422366.SGD","LU2045819591.USD","000710","603259"],"gpt_icon":1},{"id":"1182536771","title":"异动解读 | 美生物安全法案短期内或难获通过 利好药明合联股价盘中大涨6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=1182536771","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182536771?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:30","pubTimestamp":1733707835,"startTime":"0","endTime":"0","summary":"香港股市今日早盘,港股医药股药明合联股价大涨6.09%。据分析,这与最新消息显示,美国2025财年国防授权法案没有提及生物安全法案或任何与药明系相关的内容存在一定关联。市场分析人士认为,这一进展打消了投资者的一些疑虑,暂时缓解了生物安全法案可能对药明系等中国CRO/CDMO公司海外业务产生的潜在冲击。摩根士丹利评估,鉴于此,生物安全法案在年内获得通过的可能性大大降低,这对药明系和其他具有重大海外收入的中国CRO/CDMO公司有利。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 美生物安全法案短期内或难获通过 利好药明合联股价盘中大涨6.09%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02268"],"gpt_icon":0},{"id":"2490767104","title":"药明合联盘中异动 快速拉升7.48%报30.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490767104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490767104?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:30","pubTimestamp":1733707807,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘09时30分，药明合联股票出现异动，股价快速拉升7.48%。截至发稿，该股报30.900港元/股，成交量29.6万股，换手率0.02%，振幅2.61%。资金方面，该股资金流入259.31万港元，流出38.1675万港元。药明合联股票所在的生物技术行业中，整体涨幅为1.93%。其相关个股中，圣诺医药-B、药明康德、药明生物涨幅较大，振幅较大的相关个股有荣昌生物、再鼎医药、药明生物，振幅分别为3.50%、2.98%、2.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093007a1df0117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093007a1df0117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2490648887","title":"【券商聚焦】摩根士丹利称美国生物安全法案年内通过的可能性大大降低 利好药明系","url":"https://stock-news.laohu8.com/highlight/detail?id=2490648887","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490648887?lang=zh_cn&edition=full","pubTime":"2024-12-09 08:55","pubTimestamp":1733705759,"startTime":"0","endTime":"0","summary":"金吾财讯 | 摩根士丹利称，美国2025财年国防授权法案(NDAA)没有生物安全法案或任何药明系的名字，这对药明系和其他具有重大海外收入敞口的中国CRO（合同研究组织）/CDMO（合同研发生产组织）公司是一个积极的进展。投行Jefferies也在报告中称，进展超出投资者预期，考虑到估值吸引力和投资者的低仓位，现在是重新审视中国CDMO公司的关键节点。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/ZWZlMGNjODY1NzQ4NjMzODA5NjU5ODM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZWZlMGNjODY1NzQ4NjMzODA5NjU5ODM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1949185","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","LU0307460666.USD","SG9999002562.SGD","BK1576","LU0158827781.USD","LU0314104364.USD","LU1242518931.SGD","LU0588546209.SGD","02359","LU0516423174.USD","LU0225283273.USD","LU0327786744.USD","02269","LU1880383366.USD","LU2023251221.USD","BK4504","LU1989772840.SGD","LU1989772923.USD","LU0359201612.USD","LU0516423091.SGD","LU0052750758.USD","02268","LU2125910500.SGD","LU0456827905.SGD","LU0359202008.SGD","LU0819121731.USD","BK1141","MS","LU0417516902.SGD","LU0856984785.SGD","LU0267386448.USD","BK1583","LU0320764599.SGD","LU2271345857.HKD","SG9999002463.SGD","IE00BKVL7J92.USD","LU0823426308.USD","LU0456846285.SGD","LU1720050803.USD","LU1548497426.USD","LU0181495838.USD","LU2028103732.USD","LU2242644610.SGD","BK4534","LU2089283258.USD","LU2089284900.SGD","BK4585","LU2045819591.USD","LU0971096721.USD","LU2111349929.HKD"],"gpt_icon":0},{"id":"2489077421","title":"药明合联盘中异动 快速拉升5.26%报29.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489077421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489077421?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:25","pubTimestamp":1733455506,"startTime":"0","endTime":"0","summary":"2024年12月06日早盘11时25分，药明合联股票出现异动，股价大幅上涨5.26%。截至发稿，该股报29.000港元/股，成交量291.451万股，换手率0.24%，振幅6.35%。资金方面，该股资金流入4739.49万港元，流出2595.24万港元。药明合联股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，北海康成-B、巨子生物、云康集团涨幅较大，振幅较大的相关个股有北海康成-B、来凯医药-B、永泰生物-B，振幅分别为36.92%、13.75%、13.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206112506ab617919&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206112506ab617919&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268"],"gpt_icon":0},{"id":"2489896421","title":"药明合联(02268)股价上升5.082%，现价港币$28.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2489896421","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489896421?lang=zh_cn&edition=full","pubTime":"2024-12-06 11:25","pubTimestamp":1733455500,"startTime":"0","endTime":"0","summary":"[上升股]药明合联(02268) 股价在上午11:25比前收市价上升5.082%，现股价为港币$28.95。至目前为止，今日最高价为$28.95，而最低价为$27.25。总成交量为290.401万股，总成交金额为港币$8.208千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2412062611/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2489447351","title":"南向资金12月5日净买入药明合联49.35万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2489447351","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489447351?lang=zh_cn&edition=full","pubTime":"2024-12-06 09:30","pubTimestamp":1733448614,"startTime":"0","endTime":"0","summary":"12月5日, 南向资金增持药明合联49.35万股，连续7日增持。截止当日收盘，港股通共持有药明合联11906.72万股，占流通股9.92%。药明合联近5个交易日上涨3.96%，港股通累计增持213.59万股；近20个交易日上涨7.20%，港股通累计增持1722.41万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093222ab6136ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206093222ab6136ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","BK1141"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.youyuan.com.hk","stockEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":0.3179},{"period":"3month","weight":0.5969},{"period":"6month","weight":0.7447},{"period":"1year","weight":-0.028},{"period":"ytd","weight":-0.0219}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范（GMP）生产。该公司透过按有偿服务（FFS）基准的合约和按全时当量（FTE）基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}